Literature DB >> 25070387

Evaluation of post-contrast myocardial t1 in duchenne muscular dystrophy using cardiac magnetic resonance imaging.

Jonathan H Soslow1, Bruce M Damon, Benjamin R Saville, Zengqi Lu, W Bryan Burnette, Mark A Lawson, David A Parra, Douglas B Sawyer, Larry W Markham.   

Abstract

The objective of the study was to perform a retrospective pilot study to evaluate the potential of myocardial T1 in assessment of Duchenne muscular dystrophy (DMD) cardiomyopathy. Early identification of DMD cardiac disease, particularly myocardial fibrosis, would allow earlier therapy, potentially improving outcomes. Shortened myocardial T1 measured by cardiac MRI (CMR) is a measure of cardiac fibrosis that may be detected before late gadolinium enhancement (LGE). We hypothesized that the post-contrast T1 obtained from the Look-Locker sequences (T1LL), an easily obtainable surrogate of myocardial T1, would be abnormally shortened in DMD compared with controls. T1LL measurement was performed on 21 DMD subjects and 11 controls; to account for individual variations in gadolinium distribution, myocardial T1LL was divided by blood pool T1LL, deriving T1LL ratios. DMD subjects had shorter mean T1LL ratio than controls (1.42 vs 1.72, p < 0.001). Subset analyses in DMD subjects with normal LVEF and without LGE also demonstrated significantly shorter T1LL ratio (-0.28, p < 0.001 and -0.25, p = 0.028). Post-contrast T1LL ratio is abnormally shortened in DMD compared with controls, even in DMD patients with otherwise normal CMRs. The application of more aggressive therapy for those with shorter T1LL may favorably alter morbidity and improve mortality associated with DMD cardiomyopathy. These data suggest that further prospective evaluation of myocardial T1 will be of benefit to patients with DMD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25070387      PMCID: PMC4439095          DOI: 10.1007/s00246-014-0963-x

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  30 in total

Review 1.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

2.  Nuclear magnetic resonance relaxometry of the normal heart: relationship between collagen content and relaxation times of the four chambers.

Authors:  T D Scholz; S R Fleagle; T L Burns; D J Skorton
Journal:  Magn Reson Imaging       Date:  1989 Nov-Dec       Impact factor: 2.546

3.  Skeletal, cardiac, and smooth muscle failure in Duchenne muscular dystrophy.

Authors:  B J Boland; P L Silbert; R V Groover; P C Wollan; M D Silverstein
Journal:  Pediatr Neurol       Date:  1996-01       Impact factor: 3.372

4.  The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy.

Authors:  G Nigro; L I Comi; L Politano; R J Bain
Journal:  Int J Cardiol       Date:  1990-03       Impact factor: 4.164

5.  The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis.

Authors:  K A Frankel; R J Rosser
Journal:  Hum Pathol       Date:  1976-07       Impact factor: 3.466

6.  Autopsy analyses of the muscular dystrophies.

Authors:  T Moriuchi; N Kagawa; M Mukoyama; K Hizawa
Journal:  Tokushima J Exp Med       Date:  1993-06

7.  Thallium-201 single photon emission computed tomography (SPECT) in patients with duchenne's progressive muscular dystrophy: a histopathologic correlation study.

Authors:  T Nishimura; A Yanagisawa; H Sakata; K Sakata; K Shimoyama; T Ishihara; H Yoshino; K Ishikawa
Journal:  Jpn Circ J       Date:  2001-02

8.  An ultrastructural basis for electrocardiographic alterations associated with Duchenne's progressive muscular dystrophy.

Authors:  S K Sanyal; W W Johnson; M K Thapar; S E Pitner
Journal:  Circulation       Date:  1978-06       Impact factor: 29.690

9.  Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function.

Authors:  Kan N Hor; Michael D Taylor; Hussein R Al-Khalidi; Linda H Cripe; Subha V Raman; John L Jefferies; Robert O'Donnell; D Woodrow Benson; Wojciech Mazur
Journal:  J Cardiovasc Magn Reson       Date:  2013-12-21       Impact factor: 5.364

10.  Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing.

Authors:  Jeanette Schulz-Menger; David A Bluemke; Jens Bremerich; Scott D Flamm; Mark A Fogel; Matthias G Friedrich; Raymond J Kim; Florian von Knobelsdorff-Brenkenhoff; Christopher M Kramer; Dudley J Pennell; Sven Plein; Eike Nagel
Journal:  J Cardiovasc Magn Reson       Date:  2013-05-01       Impact factor: 5.364

View more
  16 in total

Review 1.  Cardiomyopathy in becker muscular dystrophy: Overview.

Authors:  Rady Ho; My-Le Nguyen; Paul Mather
Journal:  World J Cardiol       Date:  2016-06-26

2.  Interleukin 1 Receptor-Like 1 Protein (ST2) is a Potential Biomarker for Cardiomyopathy in Duchenne Muscular Dystrophy.

Authors:  Julia Anderson; Haeri Seol; Heather Gordish-Dressman; Yetrib Hathout; Christopher F Spurney
Journal:  Pediatr Cardiol       Date:  2017-08-18       Impact factor: 1.655

Review 3.  Neuromuscular diseases and their cardiac manifestations under the spectrum of cardiovascular imaging.

Authors:  Georgios M Alexandridis; Efstathios D Pagourelias; Nikolaos Fragakis; Maria Kyriazi; Efthymia Vargiami; Dimitrios Zafeiriou; Vassilios P Vassilikos
Journal:  Heart Fail Rev       Date:  2022-07-20       Impact factor: 4.654

Review 4.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the Use of Cardiac Magnetic Resonance in Pediatric Congenital and Acquired Heart Disease: Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  Circ Cardiovasc Imaging       Date:  2022-06-21       Impact factor: 8.589

Review 5.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the use of cardiovascular magnetic resonance in pediatric congenital and acquired heart disease : Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  J Cardiovasc Magn Reson       Date:  2022-06-21       Impact factor: 6.903

6.  Elevated Myocardial Extracellular Volume Fraction in Duchenne Muscular Dystrophy.

Authors:  James J Starc; Ryan A Moore; Mantosh S Rattan; Chet R Villa; Zhiqian Gao; Wojciech Mazur; John L Jefferies; Michael D Taylor
Journal:  Pediatr Cardiol       Date:  2017-07-31       Impact factor: 1.655

7.  Tissue characterisation and myocardial mechanics using cardiac MRI in children with hypertrophic cardiomyopathy.

Authors:  Sudeep Sunthankar; David A Parra; Kristen George-Durrett; Kimberly Crum; Joshua D Chew; Jason Christensen; Frank J Raucci; Meng Xu; James C Slaughter; Jonathan H Soslow
Journal:  Cardiol Young       Date:  2019-11-26       Impact factor: 1.093

8.  Duchenne muscular dystrophy patients: troponin leak in asymptomatic and implications for drug toxicity studies.

Authors:  Larry W Markham; Jonathan H Soslow; Aryaz Sheybani; Kim Crum; Frank J Raucci; William B Burnette
Journal:  Pediatr Res       Date:  2021-08-24       Impact factor: 3.756

9.  Translating golden retriever muscular dystrophy microarray findings to novel biomarkers for cardiac/skeletal muscle function in Duchenne muscular dystrophy.

Authors:  Cristi L Galindo; Jonathan H Soslow; Candice L Brinkmeyer-Langford; Manisha Gupte; Holly M Smith; Seng Sengsayadeth; Douglas B Sawyer; D Woodrow Benson; Joe N Kornegay; Larry W Markham
Journal:  Pediatr Res       Date:  2015-12-16       Impact factor: 3.756

10.  Increased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophy.

Authors:  Jonathan H Soslow; Stephen M Damon; Kimberly Crum; Mark A Lawson; James C Slaughter; Meng Xu; Andrew E Arai; Douglas B Sawyer; David A Parra; Bruce M Damon; Larry W Markham
Journal:  J Cardiovasc Magn Reson       Date:  2016-01-21       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.